用新方法从稀疏患者报告数据中挖掘溃疡性结肠炎分型特征。
Supervised Coupled Matrix-Tensor Factorization (SCMTF) for Computational Phenotyping of Patient Reported Outcomes in Ulcerative Colitis
- 提出监督式耦合矩阵-张量分解,融合动态症状与静态指标预测用药持续性。
- 模型在8和20个月后预测用药变化的AUC分别达0.853和0.803。
- 首次将张量方法用于溃疡性结肠炎患者报告数据,发现症状变量具预测价值。
表型分型旨在区分患者群体以识别疾病进展的不同类型。近年来,低秩矩阵与张量分解因其处理多模态、异构及缺失数据的能力而受到关注。症状量化对理解炎症性肠病(如溃疡性结肠炎,UC)患者的体验至关重要,但患者报告的症状通常噪声大、主观性强,且比其他数据更稀疏,因此常被排除在分型及其他机器学习方法之外。本文探索使用新型监督式耦合矩阵-张量分解(SCMTF)方法,整合时间序列患者报告结果(PROs)与实验室数据及静态特征,以预测溃疡性结肠炎患者的药物持续使用情况。这是首个兼具监督与耦合特性的张量方法,首次应用于UC领域及PRO数据。我们采用深度学习框架,提升模型灵活性与可训练性,有效处理PROs中的大量缺失数据。最佳模型在测试集上对8个月和20个月后的用药变化预测的AUC分别为0.853和0.803。所提取的可解释表型包含静态特征与时间特征及其动态模式。结果表明,基于低秩矩阵与张量的分型方法可成功应用于UC领域及高度缺失的PRO数据,并识别出与用药持续性相关的表型,包括多个症状变量,证明了通常被忽略的PROs中蕴含重要信息。
原文摘要 · Abstract (English)
Phenotyping is the process of distinguishing groups of patients to identify different types of disease progression. A recent trend employs low-rank matrix and tensor factorization methods for their capability of dealing with multi-modal, heterogeneous, and missing data. Symptom quantification is crucial for understanding patient experiences in inflammatory bowel disease, especially in conditions such as ulcerative colitis (UC). However, patient-reported symptoms are typically noisy, subjective, and significantly more sparse than other data types. For this reason, they are usually not included in phenotyping and other machine learning methods. This paper explores the application of computational phenotyping to leverage Patient-Reported Outcomes (PROs) using a novel supervised coupled matrix-tensor factorization (SCMTF) method, which integrates temporal PROs and temporal labs with static features to predict medication persistence in ulcerative colitis. This is the first tensor-based method that is both supervised and coupled, it is the first application to the UC domain, and the first application to PROs. We use a deep learning framework that makes the model flexible and easy to train. The proposed method allows us to handle the large amount of missing data in the PROs. The best model predicts changes in medication 8 and 20 months in the future with AUCs of 0.853 and 0.803 on the test set respectively. We derive interpretable phenotypes consisting of static features and temporal features (including their temporal patterns). We show that low-rank matrix and tensor based phenotyping can be successfully applied to the UC domain and to highly missing PRO data. We identify phenotypes useful to predict medication persistence - these phenotypes include several symptom variables, showing that PROs contain relevant infromation that is usually discarded.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。